Additionally, GDF15 is highly expressed in T cells from recurrent tumors, which may be associated with antigen recognition and the inhibition of anti‐tumor immune responses.[13]ARG2, an immune inhibitory molecule, is highly expressed at high levels in CD8+ T and Treg cells. This evidence concerns the gene ARG2 and neoplasm.